Bottom line
How much do FBDIX and SHPAX overlap?
19% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 16.9% of FBDIX's assets and 18.4% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
FBDIX holds far more positions (126 vs 29), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBDIX and SHPAX have in common
| Holding | % of FBDIX | % of SHPAX | Overlap |
|---|---|---|---|
| Amgen, Inc. | 4.39% | 5.04% | 4.39% |
| Gilead Sciences, Inc. | 3.86% | 3.94% | 3.86% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 3.93% | 3.77% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 3.36% | 3.36% |
| Eli Lilly & Co. | 1.31% | 2.11% | 1.31% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Argenx SE — 3.62%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
- Dianthus Therapeutics, Inc. — 2.32%
- Insmed, Inc. — 1.99%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- Neurocrine Biosciences, Inc. — 1.82%
- Bridgebio Pharma, Inc. — 1.67%
- PTC Therapeutics, Inc. — 1.65%
Only in SHPAX
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Johnson & Johnson — 3.91%
- National Healthcare Corp — 3.72%
- Merck & Company Inc — 3.63%
- Cigna Group (the) — 3.63%
- Medpace Holdings Inc — 3.37%
- Intuitive Surgical Inc — 3.14%
- Bristol-myers Squibb Company — 3.07%
Asset mix
| Asset type | FBDIX | SHPAX |
|---|---|---|
| Stocks | 97.0% | 99.0% |
| Cash & short-term funds | 4.6% | 1.6% |
| Preferred stock | 1.0% | — |
| Other | 0.6% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FBDIX | SHPAX |
|---|---|---|
| US | 82.0% | 86.1% |
| IE | 6.7% | 8.4% |
| CH | 1.2% | 4.5% |
| NL | 4.5% | — |
| DK | 2.6% | 1.6% |
| FR | 1.7% | — |
| GB | 1.5% | — |
| CA | 1.3% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FBDIX and SHPAX overlap?
What stocks do FBDIX and SHPAX have in common?
Should I own both FBDIX and SHPAX?
Which holds more stocks, FBDIX or SHPAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.